Titre : Syndrome des anticorps antiphospholipides

Syndrome des anticorps antiphospholipides : Questions médicales fréquentes

Termes MeSH sélectionnés :

Streptococcus pyogenes
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Syndrome des anticorps antiphospholipides : Questions médicales les plus fréquentes", "headline": "Syndrome des anticorps antiphospholipides : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Syndrome des anticorps antiphospholipides : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-01-12", "dateModified": "2025-04-06", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Syndrome des anticorps antiphospholipides" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Maladies auto-immunes", "url": "https://questionsmedicales.fr/mesh/D001327", "about": { "@type": "MedicalCondition", "name": "Maladies auto-immunes", "code": { "@type": "MedicalCode", "code": "D001327", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C20.111" } } }, "about": { "@type": "MedicalCondition", "name": "Syndrome des anticorps antiphospholipides", "alternateName": "Antiphospholipid Syndrome", "code": { "@type": "MedicalCode", "code": "D016736", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Doruk Erkan", "url": "https://questionsmedicales.fr/author/Doruk%20Erkan", "affiliation": { "@type": "Organization", "name": "Barbara Volcker Center for Women and Rheumatic Diseases, Hospital for Special Surgery, and Weill Cornell Medicine, New York, NY, USA." } }, { "@type": "Person", "name": "Hannah Cohen", "url": "https://questionsmedicales.fr/author/Hannah%20Cohen", "affiliation": { "@type": "Organization", "name": "Department of Haematology, University College London Hospitals NHS Foundation Trust, London, UK." } }, { "@type": "Person", "name": "Imad Uthman", "url": "https://questionsmedicales.fr/author/Imad%20Uthman", "affiliation": { "@type": "Organization", "name": "Division of Rheumatology, Faculty of Medicine, American University of Beirut, Beirut, Lebanon." } }, { "@type": "Person", "name": "Katrien M J Devreese", "url": "https://questionsmedicales.fr/author/Katrien%20M%20J%20Devreese", "affiliation": { "@type": "Organization", "name": "Coagulation Laboratory, Ghent University Hospital, Department of Diagnostic Sciences, Ghent University, Ghent, Belgium." } }, { "@type": "Person", "name": "Yu Zuo", "url": "https://questionsmedicales.fr/author/Yu%20Zuo", "affiliation": { "@type": "Organization", "name": "Division of Rheumatology, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan, USA." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "IdeS, a secreted proteinase of Streptococcus pyogenes, is bound to a nuclease at the bacterial surface where it inactivates opsonizing IgG antibodies.", "datePublished": "2023-10-12", "url": "https://questionsmedicales.fr/article/37838172", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.jbc.2023.105345" } }, { "@type": "ScholarlyArticle", "name": "Genomic Characterization of Skin and Soft Tissue Streptococcus pyogenes Isolates from a Low-Income and a High-Income Setting.", "datePublished": "2022-12-12", "url": "https://questionsmedicales.fr/article/36507654", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1128/msphere.00469-22" } }, { "@type": "ScholarlyArticle", "name": "Decrease of hospital- and community-acquired bloodstream infections due to Streptococcus pneumoniae and Streptococcus pyogenes during the first year of the COVID-19 pandemic: A time-series analysis in Paris region.", "datePublished": "2022-09-15", "url": "https://questionsmedicales.fr/article/36115540", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.ajic.2022.09.002" } }, { "@type": "ScholarlyArticle", "name": "Impact of COVID-19 health precautions on asymptomatic Streptococcus pyogenes carriage in palestinian children: a pre- and post-pandemic study.", "datePublished": "2024-10-04", "url": "https://questionsmedicales.fr/article/39367303", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s12879-024-10023-w" } }, { "@type": "ScholarlyArticle", "name": "Carvacrol inhibits Streptococcus pyogenes biofilms by suppressing the expression of genes associated with quorum-sensing and reducing cell surface hydrophobicity.", "datePublished": "2022-07-19", "url": "https://questionsmedicales.fr/article/35863588", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.micpath.2022.105684" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Maladies du système immunitaire", "item": "https://questionsmedicales.fr/mesh/D007154" }, { "@type": "ListItem", "position": 3, "name": "Maladies auto-immunes", "item": "https://questionsmedicales.fr/mesh/D001327" }, { "@type": "ListItem", "position": 4, "name": "Syndrome des anticorps antiphospholipides", "item": "https://questionsmedicales.fr/mesh/D016736" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Syndrome des anticorps antiphospholipides - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Syndrome des anticorps antiphospholipides", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-07", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Syndrome des anticorps antiphospholipides", "description": "Comment diagnostique-t-on le syndrome des anticorps antiphospholipides ?\nQuels tests sont utilisés pour le diagnostic ?\nQuels critères sont utilisés pour le diagnostic ?\nLe diagnostic nécessite-t-il des symptômes cliniques ?\nPeut-on avoir le syndrome sans symptômes ?", "url": "https://questionsmedicales.fr/mesh/D016736?mesh_terms=Streptococcus+pyogenes&page=3#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Syndrome des anticorps antiphospholipides", "description": "Quels sont les symptômes courants du syndrome ?\nLe syndrome peut-il causer des douleurs ?\nY a-t-il des symptômes neurologiques associés ?\nLes symptômes varient-ils d'une personne à l'autre ?\nLe syndrome affecte-t-il la grossesse ?", "url": "https://questionsmedicales.fr/mesh/D016736?mesh_terms=Streptococcus+pyogenes&page=3#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Syndrome des anticorps antiphospholipides", "description": "Comment prévenir les complications du syndrome ?\nY a-t-il des changements de mode de vie recommandés ?\nLes femmes enceintes doivent-elles être surveillées ?\nLes vaccinations sont-elles importantes ?\nLe stress a-t-il un impact sur le syndrome ?", "url": "https://questionsmedicales.fr/mesh/D016736?mesh_terms=Streptococcus+pyogenes&page=3#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Syndrome des anticorps antiphospholipides", "description": "Quels traitements sont disponibles pour le syndrome ?\nLes anticoagulants sont-ils efficaces ?\nLe traitement est-il à vie ?\nY a-t-il des effets secondaires aux traitements ?\nLes femmes enceintes peuvent-elles être traitées ?", "url": "https://questionsmedicales.fr/mesh/D016736?mesh_terms=Streptococcus+pyogenes&page=3#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Syndrome des anticorps antiphospholipides", "description": "Quelles sont les complications possibles du syndrome ?\nLe syndrome peut-il causer des problèmes cardiaques ?\nY a-t-il des risques pour la santé mentale ?\nLes complications sont-elles réversibles ?\nLe syndrome augmente-t-il le risque de cancer ?", "url": "https://questionsmedicales.fr/mesh/D016736?mesh_terms=Streptococcus+pyogenes&page=3#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Syndrome des anticorps antiphospholipides", "description": "Quels sont les facteurs de risque du syndrome ?\nLe sexe influence-t-il le risque ?\nLes antécédents de thromboses augmentent-ils le risque ?\nLes infections virales sont-elles un facteur de risque ?\nLe tabagisme influence-t-il le risque ?", "url": "https://questionsmedicales.fr/mesh/D016736?mesh_terms=Streptococcus+pyogenes&page=3#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostique-t-on le syndrome des anticorps antiphospholipides ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic repose sur des tests sanguins pour détecter les anticorps antiphospholipides." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour le diagnostic ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Les tests incluent le lupus anticoagulant, les anticorps anti-cardiolipine et anti-bêta-2-glycoprotéine I." } }, { "@type": "Question", "name": "Quels critères sont utilisés pour le diagnostic ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Les critères incluent des antécédents de thromboses et la présence d'anticorps spécifiques." } }, { "@type": "Question", "name": "Le diagnostic nécessite-t-il des symptômes cliniques ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des antécédents de thromboses ou de complications obstétricales sont souvent requis." } }, { "@type": "Question", "name": "Peut-on avoir le syndrome sans symptômes ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certaines personnes peuvent avoir des anticorps sans présenter de symptômes cliniques." } }, { "@type": "Question", "name": "Quels sont les symptômes courants du syndrome ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent des thromboses, des fausses couches et des éruptions cutanées." } }, { "@type": "Question", "name": "Le syndrome peut-il causer des douleurs ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des douleurs peuvent survenir en raison de thromboses dans les vaisseaux sanguins." } }, { "@type": "Question", "name": "Y a-t-il des symptômes neurologiques associés ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des symptômes comme des maux de tête, des AVC ou des troubles cognitifs peuvent apparaître." } }, { "@type": "Question", "name": "Les symptômes varient-ils d'une personne à l'autre ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'intensité et la nature des symptômes peuvent varier considérablement entre les individus." } }, { "@type": "Question", "name": "Le syndrome affecte-t-il la grossesse ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, il peut entraîner des complications comme des fausses couches ou des prééclampsies." } }, { "@type": "Question", "name": "Comment prévenir les complications du syndrome ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "La prévention inclut la prise régulière d'anticoagulants et le suivi médical." } }, { "@type": "Question", "name": "Y a-t-il des changements de mode de vie recommandés ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, maintenir un poids santé, faire de l'exercice et éviter le tabac sont conseillés." } }, { "@type": "Question", "name": "Les femmes enceintes doivent-elles être surveillées ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une surveillance étroite est essentielle pour prévenir les complications obstétricales." } }, { "@type": "Question", "name": "Les vaccinations sont-elles importantes ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les vaccinations peuvent aider à prévenir certaines infections qui aggravent le syndrome." } }, { "@type": "Question", "name": "Le stress a-t-il un impact sur le syndrome ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Le stress peut exacerber les symptômes, donc des techniques de gestion du stress sont utiles." } }, { "@type": "Question", "name": "Quels traitements sont disponibles pour le syndrome ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Les traitements incluent des anticoagulants et des médicaments immunosuppresseurs." } }, { "@type": "Question", "name": "Les anticoagulants sont-ils efficaces ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les anticoagulants réduisent le risque de thromboses chez les patients atteints." } }, { "@type": "Question", "name": "Le traitement est-il à vie ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Pas toujours, mais de nombreux patients nécessitent un traitement à long terme." } }, { "@type": "Question", "name": "Y a-t-il des effets secondaires aux traitements ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les anticoagulants peuvent causer des saignements et d'autres effets indésirables." } }, { "@type": "Question", "name": "Les femmes enceintes peuvent-elles être traitées ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des anticoagulants comme l'héparine sont souvent utilisés pendant la grossesse." } }, { "@type": "Question", "name": "Quelles sont les complications possibles du syndrome ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent des thromboses veineuses profondes, des AVC et des fausses couches." } }, { "@type": "Question", "name": "Le syndrome peut-il causer des problèmes cardiaques ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, il peut augmenter le risque de maladies cardiovasculaires et d'infarctus." } }, { "@type": "Question", "name": "Y a-t-il des risques pour la santé mentale ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des troubles anxieux et dépressifs peuvent survenir chez certains patients." } }, { "@type": "Question", "name": "Les complications sont-elles réversibles ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Certaines complications peuvent être gérées, mais d'autres peuvent avoir des effets durables." } }, { "@type": "Question", "name": "Le syndrome augmente-t-il le risque de cancer ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Des études suggèrent un lien possible, mais des recherches supplémentaires sont nécessaires." } }, { "@type": "Question", "name": "Quels sont les facteurs de risque du syndrome ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs incluent des antécédents familiaux, des maladies auto-immunes et des infections." } }, { "@type": "Question", "name": "Le sexe influence-t-il le risque ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le syndrome est plus fréquent chez les femmes, surtout entre 20 et 40 ans." } }, { "@type": "Question", "name": "Les antécédents de thromboses augmentent-ils le risque ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, avoir des antécédents de thromboses augmente significativement le risque de syndrome." } }, { "@type": "Question", "name": "Les infections virales sont-elles un facteur de risque ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Certaines infections virales, comme le VIH, peuvent augmenter le risque de développer le syndrome." } }, { "@type": "Question", "name": "Le tabagisme influence-t-il le risque ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le tabagisme est associé à un risque accru de thromboses et de complications." } } ] } ] }

Sources (1548 au total)

IdeS, a secreted proteinase of Streptococcus pyogenes, is bound to a nuclease at the bacterial surface where it inactivates opsonizing IgG antibodies.

The important bacterial pathogen Streptococcus pyogenes secretes IdeS (immunoglobulin G-degrading enzyme of S. pyogenes), a proteinase that cleaves human immunoglobulin G (IgG) antibodies in the hinge...

Decrease of hospital- and community-acquired bloodstream infections due to Streptococcus pneumoniae and Streptococcus pyogenes during the first year of the COVID-19 pandemic: A time-series analysis in Paris region.

The impact of the COVID-19 pandemic on bloodstream infections (BSIs) due to Streptococcus pneumoniae and Streptococcus pyogenes was assessed in 25 university hospitals of Paris. Monthly BSIs incidence...

Impact of COVID-19 health precautions on asymptomatic Streptococcus pyogenes carriage in palestinian children: a pre- and post-pandemic study.

Streptococcus pyogenes (Group A Streptococcus, GAS) is a significant pathogen that causes diverse infections, ranging from pharyngitis to severe invasive diseases. Asymptomatic carriage in children is... This cross-sectional study was conducted in two phases: pre-COVID-19 (November 2019-January 2020) and post-COVID-19 (November 2023-April 2024). Throat swabs were collected from 701 children (345 pre-C... The prevalence of asymptomatic pharyngeal GAS carriage declined from 15.7% pre-COVID-19 to 10.4% post-COVID-19 (p = 0.038). Significant reductions were observed among urban residents (23.5-10.1%, p = ... COVID-19-related health precautions were correlated with a significant reduction in asymptomatic GAS carriage among Palestinian children. These findings suggest that public health measures, such as ma...

Carvacrol inhibits Streptococcus pyogenes biofilms by suppressing the expression of genes associated with quorum-sensing and reducing cell surface hydrophobicity.

Streptococcus pyogenes is a leading cause of chronic and acute infections, including streptococcus pharyngitis. Biofilm formation by S. pyogenes can cause tolerance against antibiotics. Although penic...

Doing a double take: when transthoracic echocardiography fails for mitral valve annuloplasty ring endocarditis with Streptococcus pyogenes: a case report.

This case highlights several complications of a late and rare presentation of culture-negative Streptococcus pyogenes endocarditis of a previously repaired mitral valve with an annuloplasty ring inclu... A 66-year-old Caucasian female with prior mitral valve prolapse status post mitral valve annuloplasty and left atrial appendage occlusion, followed by two strokes, presented with supraventricular tach... This case serves to highlight the importance of having a higher index of suspicion in any cardiac prosthesis patient for endocarditis when presenting with symptoms such as recurrent stroke, arrhythmia...

Evaluating the role of asymptomatic throat carriage of Streptococcus pyogenes in impetigo transmission in remote Aboriginal communities in Northern Territory, Australia: a retrospective genomic analysis.

Streptococcus pyogenes, or group A Streptococcus (GAS), infections contribute to a high burden of disease in Aboriginal Australians, causing skin infections and immune sequelae such as rheumatic heart... In this genomic analysis, we retrospectively applied whole genome sequencing to GAS isolates that were collected as part of an impetigo surveillance longitudinal household survey conducted in three re... We included 320 GAS isolates in our analysis: 203 (63%) from asymptomatic throat swabs and 117 (37%) from impetigo lesions. Among 64 genomic lineages (encompassing 39 emm types) we identified 264 tran... In communities with high prevalence of endemic GAS-associated skin infection, asymptomatic throat carriage is a GAS reservoir. Public health interventions such as vaccination or community infection co... Australian National Health and Medical Research Council....

Investigation of Morchella esculenta and Morchella conica for their antibacterial potential against methicillin-susceptible Staphylococcus aureus, methicillin-resistant Staphylococcus aureus and Streptococcus pyogenes.

Antimicrobial resistance is an alarming problem, especially due to emergence of methicillin-resistance Staphylococcus aureus (MRSA). World Health Organization (WHO) has already listed MRSA as a top pr...

Two Streptococcus pyogenes emm types and several anaerobic bacterial species are associated with idiopathic cutaneous ulcers in children after community-based mass treatment with azithromycin.

In yaws-endemic areas, two-thirds of exudative cutaneous ulcers (CU) are associated with Treponema pallidum subsp. pertenue (TP) and Haemophilus ducreyi (HD); one-third are classified as idiopathic ul... We sequenced DNA extracted from 244 CU specimens separated into four groups based upon microorganism-specific PCR results (HD+, TP+, TP+HD+, and TP-HD- or IU). S. pyogenes was enriched in IU (24.71% r... Our observations confirm the association of S. pyogenes with IU in yaws-endemic areas, and suggest that additional anaerobic bacteria, but not other microorganisms, may be associated with this syndrom...